SGX-listed Singapore eDevelopment Ltd (“SeD”, SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic,…
SGX-listed Singapore eDevelopment Ltd (“SeD”, SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic,…